Lv1
54 积分 2024-05-17 加入
Prevalence and predictors of cirrhosis and portal hypertension in the United States
1个月前
已完结
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
1个月前
已完结
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
1个月前
已完结
Liver stiffness progression in biopsy-proven metabolic dysfunction–associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study
1个月前
已完结
Training and Performance of an Electrocardiogram-Enabled Machine Learning Model for Detection of Advanced Chronic Liver Disease
1个月前
已完结
Heart–liver co-management in MASLD: from concept to clinical practice
2个月前
已完结
Steatotic Liver Disease Has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the U.S. Veterans Health System
2个月前
已关闭
Prevalence and predictors of cirrhosis and portal hypertension in the United States
2个月前
已完结
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co‐infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End‐Stage Liver Disease as Compared to HCV Mono‐infected Patients
2个月前
已完结
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
2个月前
已完结
Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype
皖公网安备34019202002308
